Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DarioHealth Corp. - Common Stock (NQ: DRIO )

0.6990 -0.0009 (-0.13%)
Streaming Delayed Price Updated: 3:44 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DarioHealth Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on New Research in Published Journal Article
Via Investor Brand Network
10 Stocks Under $10 for 2023
In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10. 
Via InvestorPlace
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation
Article Highlights 
Via TheNewswire.com
DarioHealth: Q2 Earnings Insights
  DarioHealth (NASDAQ:DRIO) reported its Q2 earnings results on Monday, August 15, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Validates Position as Leading Provider of Integrated Solutions in Employer and Payer Markets
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Delivering, Well-Positioned in ‘High-Demand’ Market
Via Investor Brand Network
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation 
Via News Direct
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Move Device Reduces Back Pain, Study Shows
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Accounts Utilizing Multi-Chronic Solution
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announce Participation in Upcoming Conferences
Via Investor Brand Network
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2022 Financial, Corporate Report
Via Investor Brand Network
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating. 
Via Talk Markets
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q3 2022 Results, Conference Call
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Employer Contracts to Provide Full Suite of Digital Health Solutions
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces 1st Contract with Government Benefits Entity
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Promising Clinical Research for Its Biofeedback Posture Device
Via Investor Brand Network
US Stocks Open Higher Ahead Of Fed Decision, Dow Jumps 175 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 175 points on Wednesday. The Federal Reserve will announce its policy decision at 2:00 p.m. ET. The country’s central bank is... 
Via Benzinga
Looking Into DarioHealth's Return On Capital Employed
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter. 
Via Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
DarioHealth Corp. (NASDAQ: DRIO) recently announced 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2022 Financial Report, Corporate Update
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research at Conference Showing Support for Rural Areas
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Solution to Drive Digital, Seamless Experience for National Health Plan
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q2 Earnings Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Research Regarding Digital Solution on Depression, Anxiety at APA Convention
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Multi-Chronic Contract with National Employer for Full-Solution Suite
Via Investor Brand Network
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.